John Landon

Station Road, Dyfed
Newcastle Emlyn, WLS SA389BY, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

CoVaccine HT™ adjuvant is superior to Freund's in eliciting ovine polyclonal antibodies against human tumor necrosis factor-alpha.

CoVaccine HT™ adjuvant is superior to Freund's in eliciting ovine polyclonal antibodies against human tumor necrosis factor-alpha.

Journal: Advances in protein chemistry and structural biology
Published: March 20, 2022

Disease modifying drugs for rheumatological diseases: a brief history of everything.

Disease modifying drugs for rheumatological diseases: a brief history of everything.

Journal: Advances in protein chemistry and structural biology
Published: February 23, 2020

Inflammatory bowel disease and targeted oral anti-TNFα therapy.

Inflammatory bowel disease and targeted oral anti-TNFα therapy.

Journal: Advances in protein chemistry and structural biology
Published: January 31, 2020

Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.

Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.

Journal: Scientific reports
Published: January 22, 2017

Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.

Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.

Journal: Scientific reports
Published: March 16, 2016

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection.

Journal: The Journal of infectious diseases
Published: September 08, 2015

Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb.

Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb.

Journal: Toxins
Published: June 12, 2014

Production and assessment of ovine antisera for the manufacture of a veterinary adder antivenom.

Production and assessment of ovine antisera for the manufacture of a veterinary adder antivenom.

Journal: The Veterinary record
Published: March 12, 2014

Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.

Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.

Journal: Journal of immunological methods
Published: September 02, 2013

Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.

Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.

Journal: Vaccine
Published: May 16, 2013

Long-term physicochemical and immunological stability of a liquid formulated intact ovine immunoglobulin-based antivenom.

Long-term physicochemical and immunological stability of a liquid formulated intact ovine immunoglobulin-based antivenom.

Journal: Toxicon : official journal of the International Society on Toxinology
Published: August 17, 2012

Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection.

Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection.

Journal: Infection and immunity
Published: December 07, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026